Acetergamine

Acetergamine
Names
	Systematic IUPAC name N-{[(8β)-6-Methylergolin-8-yl]methyl}acetamide
	Other names 8β-acetylaminomethyl-6-methylergoline; (+)-N-Acetyl-9,10-dihydrolysergamine
Identifiers
CAS Number	3031-48-9 ;
3D model (JSmol)	Interactive image;
ChemSpider	64269;
ECHA InfoCard	100.019.281
PubChem CID	71118;
UNII	O60O0JB93O ;
CompTox Dashboard (EPA)	DTXSID201043382 ;
	InChI InChI=1S/C18H23N3O/c1-11(22)19-8-12-6-15-14-4-3-5-16-18(14)13(9-20-16)7-17(15)21(2)10-12/h3-5,9,12,15,17,20H,6-8,10H2,1-2H3,(H,19,22)/t12-,15+,17+/m0/s1 Key: SGZVEWGAZGOWGP-XGWLTEMNSA-N;
	SMILES O=C(NC[C@@H]2C[C@@H]3c4cccc1c4c(c[nH]1)C[C@H]3N(C2)C)C;
Properties
Chemical formula	C18H23N3O
Molar mass	297.402 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Acetergamine is an organic chemical compound; specifically it is a derivative of ergoline, making it a member of the ergotamine family of compounds. Acetergamine currently has no mainstream uses, however its potential as an alpha-1 blocker and vasodilator has led to it being covered in several patents concerning therapies for erectile dysfunction. It has also been investigated as a treatment for cerebellar ataxia.^[1]

References

^ Ogawa, M (2004). "Pharmacological treatments of cerebellar ataxia". Cerebellum. 3 (2). London): 107–11. doi:10.1080/147342204100032331. PMID 15233578. S2CID 21026074.

This article about an alkaloid is a stub. You can help Wikipedia by expanding it.

[1] Ogawa, M (2004). "Pharmacological treatments of cerebellar ataxia". Cerebellum. 3 (2). London): 107–11. doi:10.1080/147342204100032331. PMID 15233578. S2CID 21026074.

[1]